Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice S Tanaka, H Hikita, T Tatsumi, R Sakamori, Y Nozaki, S Sakane, Y Shiode, ... Hepatology 64 (6), 1994-2014, 2016 | 329 | 2016 |
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas M Jinushi, T Takehara, T Tatsumi, N Hiramatsu, R Sakamori, ... Journal of hepatology 43 (6), 1013-1020, 2005 | 284 | 2005 |
Cdc42 and Rab8a are critical for intestinal stem cell division, survival, and differentiation in mice R Sakamori, S Das, S Yu, S Feng, E Stypulkowski, Y Guan, V Douard, ... The Journal of clinical investigation 122 (3), 1052-1065, 2012 | 120 | 2012 |
Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production Y Myojin, H Hikita, M Sugiyama, Y Sasaki, K Fukumoto, S Sakane, ... Gastroenterology 160 (5), 1741-1754. e16, 2021 | 116 | 2021 |
Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell‐mediated induction of CD4+ CD25+ T cells with PD‐1‐dependent regulatory … M Jinushi, T Takehara, T Tatsumi, S Yamaguchi, R Sakamori, ... Immunology 120 (1), 73-82, 2007 | 105 | 2007 |
Transcriptomics identify thrombospondin‐2 as a biomarker for NASH and advanced liver fibrosis K Kozumi, T Kodama, H Murai, S Sakane, O Govaere, S Cockell, ... Hepatology 74 (5), 2452-2466, 2021 | 102 | 2021 |
CTGF mediates tumor–stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression Y Makino, H Hikita, T Kodama, M Shigekawa, R Yamada, R Sakamori, ... Cancer Research 78 (17), 4902-4914, 2018 | 100 | 2018 |
Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma H Murai, T Kodama, K Maesaka, S Tange, D Motooka, Y Suzuki, ... Hepatology 77 (1), 77-91, 2023 | 90 | 2023 |
Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2‐derived peptide‐pulsed dendritic cell vaccines S Yamaguchi, T Tatsumi, T Takehara, R Sakamori, A Uemura, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 85 | 2007 |
Wntless in Wnt secretion: molecular, cellular and genetic aspects S Das, S Yu, R Sakamori, E Stypulkowski, N Gao Frontiers in biology 7, 587-593, 2012 | 78 | 2012 |
Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice R Sakamori, T Takehara, C Ohnishi, T Tatsumi, K Ohkawa, K Takeda, ... Hepatology 46 (5), 1564-1573, 2007 | 78 | 2007 |
TLR sorting by R ab11 endosomes maintains intestinal epithelial‐microbial homeostasis S Yu, Y Nie, B Knowles, R Sakamori, E Stypulkowski, C Patel, S Das, ... The EMBO journal 33 (17), 1882-1895, 2014 | 76 | 2014 |
Intrahepatic delivery of α‐galactosylceramide‐pulsed dendritic cells suppresses liver tumor T Tatsumi, T Takehara, S Yamaguchi, A Sasakawa, R Sakamori, ... Hepatology 45 (1), 22-30, 2007 | 63 | 2007 |
Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity T Tatsumi, T Takehara, S Yamaguchi, A Sasakawa, T Miyagi, M Jinushi, ... Gene therapy 14 (11), 863-871, 2007 | 62 | 2007 |
Rab8a vesicles regulate Wnt ligand delivery and Paneth cell maturation at the intestinal stem cell niche S Das, S Yu, R Sakamori, P Vedula, Q Feng, J Flores, A Hoffman, J Fu, ... Development 142 (12), 2147-2162, 2015 | 59 | 2015 |
CDC42 inhibition suppresses progression of incipient intestinal tumors R Sakamori, S Yu, X Zhang, A Hoffman, J Sun, S Das, P Vedula, G Li, J Fu, ... Cancer research 74 (19), 5480-5492, 2014 | 59 | 2014 |
STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo R Sakamori, T Takehara, T Tatsumi, M Shigekawa, H Hikita, N Hiramatsu, ... Journal of gastroenterology 45, 244-248, 2010 | 57 | 2010 |
Visualization of pancreaticobiliary reflux in anomalous pancreaticobiliary junction by secretin‐stimulated dynamic magnetic resonance cholangiopancreatography T Hosoki, Y Hasuike, Y Takeda, T Michita, Y Watanabe, R Sakamori, ... Acta Radiologica 45 (4), 375-382, 2004 | 57 | 2004 |
Interleukin-6 is a circulating prognostic biomarker for hepatocellular carcinoma patients treated with combined immunotherapy Y Myojin, T Kodama, R Sakamori, K Maesaka, T Matsumae, Y Sawai, ... Cancers 14 (4), 883, 2022 | 55 | 2022 |
ST6GAL1 is a novel serum biomarker for lenvatinib-susceptible FGF19-driven hepatocellular carcinoma Y Myojin, T Kodama, K Maesaka, D Motooka, Y Sato, S Tanaka, Y Abe, ... Clinical Cancer Research 27 (4), 1150-1161, 2021 | 55 | 2021 |